85 related articles for article (PubMed ID: 9735869)
1. A comparison of two different systems for CD34+ selection of autologous or allogeneic PBSC collections.
Stainer CJ; Miflin G; Anderson S; Davy B; McQuaker IG; Russell NH
J Hematother; 1998 Aug; 7(4):375-83. PubMed ID: 9735869
[TBL] [Abstract][Full Text] [Related]
2. A controlled comparison of two different clinical grade devices for CD34+ cell selection of autologous blood stem cell grafts.
Björkstrand B; Sundman-Engberg B; Christensson B; Kumlien G
J Hematother; 1999 Feb; 8(1):75-80. PubMed ID: 10192304
[TBL] [Abstract][Full Text] [Related]
3. T-cell depletion of allogeneic bone marrow grafts: enrichment of mononuclear cells using the COBE Spectra cell processor, followed by immunoselection of CD34(+) cells.
Olivero S; Novakovitch G; Ladaique P; Sainty D; Viret F; Faucher C; Stoppa AM; Blaise D; Chabannon C
Cytotherapy; 1999; 1(6):469-77. PubMed ID: 20443236
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
[TBL] [Abstract][Full Text] [Related]
5. Purging and haemopoietic progenitor cell selection by CD34+ cell separation.
Krüger W; Gruber M; Hennings S; Fehse N; Fehse B; Gutensohn K; Kröger N; Zander AR
Bone Marrow Transplant; 1998 Apr; 21(7):665-71. PubMed ID: 9578305
[TBL] [Abstract][Full Text] [Related]
6. PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia.
Scimè R; Indovina A; Santoro A; Musso M; Olivieri A; Tringali S; Crescimanno A; Montanari M; Felice R; Catania P; Mariani G; Leoni P; Majolino I
Bone Marrow Transplant; 1998 Dec; 22(12):1159-65. PubMed ID: 9894718
[TBL] [Abstract][Full Text] [Related]
7. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1.
Dreger P; Viehmann K; Steinmann J; Eckstein V; Müller-Ruchholtz W; Löffler H; Schmitz N
Exp Hematol; 1995 Feb; 23(2):147-54. PubMed ID: 7530212
[TBL] [Abstract][Full Text] [Related]
8. CD34 selection using three immunoselection devices: comparison of T-cell depleted allografts.
O'Donnell PV; Myers B; Edwards J; Loper K; Rhubart P; Noga SJ
Cytotherapy; 2001; 3(6):483-8. PubMed ID: 11953032
[TBL] [Abstract][Full Text] [Related]
9. Combined positive and negative cell selection from allogeneic peripheral blood progenitor cells (PBPC) by use of immunomagnetic methods.
Martín-Henao GA; Picón M; Amill B; Querol S; Ferrà C; Grañena A; García J
Bone Marrow Transplant; 2001 Apr; 27(7):683-7. PubMed ID: 11360106
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting purification of CD34(+) peripheral blood stem cells using the Baxter Isolex 300i.
Gryn J; Shadduck RK; Lister J; Zeigler ZR; Raymond JM
J Hematother Stem Cell Res; 2002 Aug; 11(4):719-30. PubMed ID: 12201961
[TBL] [Abstract][Full Text] [Related]
11. Mobilization and selection of peripheral blood hematopoietic progenitors in children with systemic sclerosis.
Locatelli F; Perotti C; Torretta L; Maccario R; Montagna D; Ravelli A; Giorgiani G; De Benedetti F; Giraldi E; Magnani ML; De Stefano P; Martini A
Haematologica; 1999 Sep; 84(9):839-43. PubMed ID: 10477459
[TBL] [Abstract][Full Text] [Related]
12. CD34+ cell selection from frozen cord blood products using the Isolex 300i and CliniMACS CD34 selection devices.
McNiece IK; Stoney GB; Kern BP; Briddell RA
J Hematother; 1998 Oct; 7(5):457-61. PubMed ID: 9829320
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT.
Urbano-Ispizua A; Solano C; Brunet S; de la Rubia J; Odriozola J; Zuazu J; Figuera A; Caballero D; Martínez C; García J; Sanz G; Torrabadella M; Alegre A; Pérez-Oteiza J; Jurado M; Oyonarte S; Sierra J; García-Conde J; Rozman C
Bone Marrow Transplant; 1998 Sep; 22(6):519-25. PubMed ID: 9758337
[TBL] [Abstract][Full Text] [Related]
14. Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery.
Dreger P; Viehmann K; von Neuhoff N; Glaubitz T; Petzoldt O; Glass B; Uharek L; Rautenberg P; Suttorp M; Mills B; Mitsky P; Schmitz N
Bone Marrow Transplant; 1999 Jul; 24(2):153-61. PubMed ID: 10455343
[TBL] [Abstract][Full Text] [Related]
15. Predictors of high yield and purify of CD34(+) cell-selected PBPC, collected from patients with multiple myeloma.
Webb IJ; Scholssman RL; Jiroutek M; Doss D; Cohen CA; Freeman A; Schott DM; Anderson KC
Cytotherapy; 1999; 1(3):175-82. PubMed ID: 12881173
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic transplantation of purified CD34+ cells from peripheral blood: Spanish experience of 62 cases. Spanish Group of allo-PBT.
Urbano-Ispizua A; Solano C; Brunet S; de la Rubia J; Odriozola J; Zuazu J; Figuera A; Caballero D; Martínez C; García J; Sanz G; Torrabadella M; Alegre A; Pérez-Oteiza J; Jurado M; Oyonarte S; Sierra J; García-Conde J; Rozman C
Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S71-4. PubMed ID: 9712500
[TBL] [Abstract][Full Text] [Related]
17. Selection of CD34-Positive Blood Cells for Allogeneic Transplantation: Approaches to Optimize D34-Cell Recovery, Purity, Viability, and T-cell Depletion.
Fritsch G; Scharner D; Fröschl G; Buchinger P; Peters C; Matthes S; Witt V; Gadner H
Onkologie; 2000 Oct; 23(5):449-456. PubMed ID: 11441240
[TBL] [Abstract][Full Text] [Related]
18. Impact of leukapheresis cell composition on immunomagnetic cell selection with the Baxter Isolex 300i device: a statistical analysis.
Perotti C; Del Fante C; Viarengo GL; Bergamaschi P; Tinelli C; Bellotti L; Marchesi A; Parisi C; Salvaneschi L
Stem Cells Dev; 2004 Aug; 13(4):350-6. PubMed ID: 15345128
[TBL] [Abstract][Full Text] [Related]
19. Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device.
Schumm M; Lang P; Taylor G; Kuçi S; Klingebiel T; Bühring HJ; Geiselhart A; Niethammer D; Handgretinger R
J Hematother; 1999 Apr; 8(2):209-18. PubMed ID: 10349915
[TBL] [Abstract][Full Text] [Related]
20. Double T cell depletion of bone marrow using sequential positive and negative cell immunoaffinity or CD34+ cell selection followed by Campath-1M; effect on CD34+ cells and progenitor cell recoveries.
Clarke E; Potter MN; Hale G; Waldmann H; Lankester A; Cornish JM; Steward CG; Marks DI; Oakhill A; Pamphilon DH
Bone Marrow Transplant; 1998 Jul; 22(2):117-24. PubMed ID: 9707017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
